Range Low Price High Price Comment
30 days $114.38 $131.80 Tuesday, 30th Apr 2024 SRPT stock ended at $126.66. This is 1.66% less than the trading day before Monday, 29th Apr 2024. During the day the stock fluctuated 2.49% from a day low at $126.53 to a day high of $129.68.
90 days $114.38 $143.00
52 weeks $55.25 $159.89

Historical Sarepta Therapeutics prices

Date Open High Low Close Volume
Apr 30, 2024 $128.65 $129.68 $126.53 $126.66 801 260
Apr 29, 2024 $129.02 $131.80 $127.47 $128.80 756 096
Apr 26, 2024 $127.53 $131.46 $125.62 $128.77 956 749
Apr 25, 2024 $123.00 $130.61 $121.91 $127.39 1 486 719
Apr 24, 2024 $117.66 $125.13 $117.21 $124.25 1 344 079
Apr 23, 2024 $117.50 $119.90 $117.06 $117.12 440 864
Apr 22, 2024 $116.63 $118.43 $114.48 $116.96 719 404
Apr 19, 2024 $116.55 $117.74 $114.38 $115.62 622 015
Apr 18, 2024 $117.55 $118.90 $115.79 $116.55 412 805
Apr 17, 2024 $117.00 $119.08 $115.93 $117.89 524 600
Apr 16, 2024 $117.60 $118.69 $116.94 $117.29 485 279
Apr 15, 2024 $122.18 $122.99 $117.78 $118.31 752 903
Apr 12, 2024 $124.00 $124.82 $121.49 $122.87 635 558
Apr 11, 2024 $127.28 $127.49 $123.43 $124.45 544 210
Apr 10, 2024 $124.13 $126.47 $123.87 $126.31 390 163
Apr 09, 2024 $126.46 $127.41 $126.07 $126.98 278 439
Apr 08, 2024 $126.17 $126.68 $124.37 $126.39 559 098
Apr 05, 2024 $125.43 $127.64 $123.85 $126.08 279 000
Apr 04, 2024 $127.22 $128.23 $124.88 $125.79 579 222
Apr 03, 2024 $126.07 $128.60 $125.17 $126.92 632 801
Apr 02, 2024 $127.68 $128.79 $125.80 $127.00 344 917
Apr 01, 2024 $129.38 $129.38 $126.11 $128.40 857 300
Mar 28, 2024 $131.16 $131.16 $127.83 $129.46 771 176
Mar 27, 2024 $129.25 $130.32 $127.36 $130.23 547 000
Mar 26, 2024 $129.83 $129.97 $128.00 $128.25 509 433
Click to get the best stock tips daily for free!

About Sarepta Therapeutics

Sarepta Therapeutics Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; and VYONDYS 53 for the treatment of ... SRPT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT